The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available that are not considered orphan products.

• Adalimumab (Brand name: Humira) - Manufactured by AbbVie Inc.
  FDA-approved indication: September 2018, adalimumab (Humira) received expanded approval for the treatment of non-infectious intermediate, posterior, and panuveitis to include pediatric patients 2 years of age and older. It was approved for use in adults with non-infectious intermediate, posterior, and panuveitis in June 2016.
  National Library of Medicine Drug Information Portal Medline Plus Health Information

  Learn more about Panuveitis

• Dexamethasone Intravitreal Implant (Brand name: Ozurdex) - Manufactured by Allergan
  FDA-approved indication: For treating non-infectious ocular inflammation, or uveitis, affecting eye's posterior segment
  National Library of Medicine Drug Information Portal

  Learn more about Panuveitis